Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Darifenacin[1] Darifenacin (Darifenacin hydrobromide)[2] Darifenacin hydrobromide (Darifenacin hydrobromide),
Darifenacin (Darifenacin) 💬
[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[4] 2, 6, 13, 26 💬
2Darifenacin (BAY79-4998)[1] Darifenacin (Darifenacin hydrobromide)[2] Darifenacin hydrobromide (Darifenacin hydrobromide),
Darifenacin (Darifenacin) 💬
[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[1] 13 💬
3Darifenacin 7.5 MG Extended Release Oral Tablet[1] Darifenacin (Darifenacin hydrobromide)[2] Darifenacin hydrobromide (Darifenacin hydrobromide),
Darifenacin (Darifenacin) 💬
[1] CHRM3 💬 [12] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬[1] 2 💬
4Oxybutynin and darifenacin[2] Darifenacin (Darifenacin hydrobromide),
Oxybutynin
[4] Oxybutynin ,
Oxybutynin chloride ,
Darifenacin hydrobromide (Darifenacin hydrobromide),
Darifenacin (Darifenacin) 💬
[5] CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬
[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬[1] 6 💬